STOCK TITAN

Zenas BioPharma: Wellington reports 12.42% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Zenas BioPharma, Inc. (ZBIO) common stock was the subject of an amended ownership report by Wellington Management Group LLP, Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP and Wellington Management Company LLP. Each reported the same aggregate beneficial ownership of 8,094,339 shares, equal to 12.42% of the class, as of September 30, 2026; these figures are overlapping reports, not separate holdings to add together. The first three entities reported shared voting power over 7,705,121 shares and shared dispositive power over 8,094,339 shares. Wellington Management Company LLP reported shared voting power over 7,697,151 shares and shared dispositive power over 7,891,827 shares. The shares are owned of record by clients of Wellington investment advisers.

Aggregate beneficial ownership 8,094,339 shares Each of the four reporting persons reported this amount as of September 30, 2026.
Percent of class 12.42% Ownership percentage reported in Item 4.
Shared voting power 7,705,121 shares Reported by Wellington Management Group LLP, Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP.
Shared dispositive power 8,094,339 shares Reported by Wellington Management Group LLP, Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP.
Shared voting power 7,697,151 shares Reported by Wellington Management Company LLP.
Shared dispositive power 7,891,827 shares Reported by Wellington Management Company LLP.
beneficially owned technical
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power technical
"Shared Voting Power 7,705,121.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power technical
"Shared Dispositive Power 8,094,339.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ZBIO shares did Wellington report beneficially owning?

The four Wellington reporting persons each reported aggregate beneficial ownership of 8,094,339 shares, equal to 12.42% of ZBIO common stock as of September 30, 2026.

Who receives dividends or sale proceeds from the ZBIO shares reported by Wellington?

The shares are owned of record by clients of the Wellington investment advisers, which have the right to receive or direct the receipt of dividends and sale proceeds. Vanguard Health Care Fund is named as an exception to the statement that no client is known to have those rights for more than 5% of the class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





98937L105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Wellington Management Group LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Group Holdings LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Investment Advisors Holdings LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026
Wellington Management Company LLP
Signature:Matthew Revell
Name/Title:Compliance Manager
Date:11/16/2026

Keep reading